Chicago, Illinois (PRWEB) January 20, 2016
Analyte Health, a digital health company specializing in telehealth and diagnostic testing, announced today that Christopher Jowett has joined the company as Chief Product Officer, reporting to CEO Dr. Frank Cockerill.
Mr. Jowett will lead the expansion of the Analyte Health product line, establishing broader consumer access to laboratory testing for diagnosis and monitoring of disease. Analyte Health sets the standard for improving access to convenient and affordable care for the detection, treatment and prevention of infectious and chronic disease with on-demand digital access to medical providers and follow-up care.
For the past 25 years, Chris has worked with global teams at Abbott Laboratories developing diagnostic products in Infectious Disease, Oncology, Genetics, and Diabetes. He has had multiple leadership roles with Abbott Diagnostics, Abbott Diabetes, and Abbott Molecular leading the development and global launch of diagnostic assays and automated instruments providing improved testing solutions for the core laboratory and at the point of care. His leadership managing cross-functional teams and collaborating with physicians, laboratories and the pharmaceutical industry has facilitated the development of innovative diagnostic assays to improve healthcare around the world.
“I am thrilled to welcome Chris to our leadership team,” said Frank Cockerill, Chief Executive Officer. “His background in the field of diagnostics will help catapult Analyte Health into new clinical areas to deliver high impact results for health consumers and our partners.”
“My passion is improving ways we can make a difference in people’s health and wellness,” said Christopher Jowett. “It’s exciting to join the leadership team at Analyte Health as we build on our success and implement ways we can improve consumer access to diagnostics and leverage new and innovative technologies.”
Read more about Analyte Health here: http://www.analytehealth.com/about-us/
About Analyte Health, Inc.
Analyte Health is a digital healthcare company specializing in diagnostics and care delivery. Its mission is to provide convenient access to education, navigation, diagnostic testing, personalized results and recommendations to consumers through its digital clinics. Analyte Health offers access via the phone and the web to a national team of doctors and partner diagnostic labs. More information about the company is available at http://www.AnalyteHealth.com.
Analyte Health, Inc. is a privately held company. This press release may be deemed to contain forward-looking statements, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected benefits to consumers from using Analyte Health's services. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results due to a variety of risks and uncertainties, including, among other things, the potential impact of regulatory and third party payer developments in the field of telehealth, general business and economic conditions, changes in arrangements with vendors or suppliers, and costs or delays in obtaining or maintaining regulatory approvals and licenses. Any forward-looking statements in this release are based on limited information currently available to Analyte Health, which is subject to change, and Analyte Health will not necessarily update the information.
CONTACT: Michelle Sobel, 708-602-2607, michelle(at)analytehealth(dot)com